Table 1.

Mortality during treatment

Transplanted cells	Treatment	Day of treatment (spleen size)
1.5 × 106 Bcr-Abl BM	vehicle	day 8 (380 mg), day 12 (n.a.)
1.5 × 106 Bcr-Abl BM	vehicle + IgG	day 9 (274 mg), day 12 (410 mg), day 13 (77 mg)
1.5 × 106 Bcr-Abl BM	nilotinib	none
1.5 × 106 Bcr-Abl BM	nilotinib + infliximab	day 7 (91 mg), day 9 (108 mg)
1.5 × 106 wt BM	vehicle	none